Epzicom
- Product NDC
- 49349-701
- 11-digit product format
- 493490701
- Labeler code
- 49349
- Product ID
- 49349-701_d9d63875-a435-479f-ae39-e83ad7462d93
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abacavir Sulfate and Lamivudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- NDA021652
- Marketing category
- NDA
- Marketing start
- 2011-09-12
- Marketing end
- 0000-00-00
- Substance
- ABACAVIR SULFATE; LAMIVUDINE
- Active strength
- 600 mg/1; mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#